Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.8.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Dec. 31, 2016
Cash $ 9,946,654 $ 2,988 $ 185,151 $ 5,898
Working capital deficiency 2,212,757      
Accumulated deficit 154,231,190   156,435,278  
Net income 2,204,088 (3,097,732)    
Loss from operations 3,801,939 $ 1,690,793    
Cash balances in excess of fdic insurance limits $ 9,679,329   $ 0  
Number of common shares issued 25,669      
Warrants to purchase shares of common stock 1,703,429      
Warrant exercise price $ 4.25      
Aggregate fair value of common stock and warrants $ 2,205,430      
Issuance of common stock to exercise of warrants 957,619      
Proceeds from warrants $ 4,069,881      
Repayment of delinquent payroll taxes $ 483,620      
Number of common stock retired during period 2,942,099      
Revenue recognition, contract liabilities $ 224,434      
Deferred revenue $ 95,000      
Sales Revenue, Net [Member] | Entity A [Member] | Maximum [Member]        
Concentration risk, percentage   10.00%    
Accounts Receivable [Member] | Entity A [Member] | Maximum [Member]        
Concentration risk, percentage 10.00%   10.00%  
Accounts Receivable [Member] | Entity B [Member]        
Concentration risk, percentage   39.00% 32.00%  
Series D Convertible Preferred Stock [Member]        
Conversion of stock, shares converted 4,368      
Common Stock [Member]        
Net income      
Conversion of stock, shares converted 1,400,000